---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-25-000132"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2025-08-28T23:59:59+00:00"
generated_at: "2026-05-17T09:29:24.059441+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Immunovant shareholders elect all three director nominees, ratify auditor, approve say-on-pay

## Summary
- Jacob Bauer, Douglas Hughes, and Robert Susman elected to Board until 2026 annual meeting.
- Ernst & Young ratified as independent auditor for FY ending March 31, 2026 (165.4M for, 7K against).
- Non-binding advisory vote on named executive officer compensation approved (159.0M for, 1.2M against).
- Approximately 97% of outstanding shares represented at the meeting.

## SEC filing metadata
- accession: 0001764013-25-000132
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2025-08-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000132/0001764013-25-000132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000132/imvt-20250827.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-25-000132
- JSON: https://secwatch.observer/filing/0001764013-25-000132.json
- Plain text: https://secwatch.observer/filing/0001764013-25-000132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.